Invention Grant
- Patent Title: Use of pridopidine to improve cognitive function and for treating Alzheimer's disease
-
Application No.: US16591875Application Date: 2019-10-03
-
Publication No.: US11471449B2Publication Date: 2022-10-18
- Inventor: Michal Geva , Ilya Bezprozvanny , Merav Bassan , Michael Hayden
- Applicant: PRILENIA NEUROTHERAPEUTICS LTD. , THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Applicant Address: IL Herzliya; US TX Austin
- Assignee: PRILENIA NEUROTHERAPEUTICS LTD.,THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee: PRILENIA NEUROTHERAPEUTICS LTD.,THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee Address: IL Herzliya; US TX Austin
- Agency: Pearl Cohen Zedek Latzer Baratz LLP
- Agent Mark S. Cohen
- Main IPC: A61P25/08
- IPC: A61P25/08 ; A61K31/451 ; A61P25/28 ; A61K45/06
Abstract:
This invention provides a method of improving cognitive function in a subject comprising periodically administering to the subject an amount of pridopidine or a pharmaceutically acceptable salt thereof effective to improve a cognitive function in the subject.
The invention also provides a method of treating a subject afflicted with Alzheimer's disease, comprising periodically administering to the subject a pharmaceutical composition comprising an amount of pridopidine or a pharmaceutically acceptable salt thereof effective to treat the subject.
The invention also provides a method of treating a subject afflicted with Alzheimer's disease, comprising periodically administering to the subject a pharmaceutical composition comprising an amount of pridopidine or a pharmaceutically acceptable salt thereof effective to treat the subject.
Public/Granted literature
- US20200093813A1 USE OF PRIDOPIDINE TO IMPROVE COGNITIVE FUNCTION AND FOR TREATING ALZHEIMER'S DISEASE Public/Granted day:2020-03-26
Information query
